The success of anti-PD-1 with chemotherapy for esophageal squamous cell carcinoma

por van Laarhoven, Hanneke W.M., Derks, Sarah
Publicado 2023

SPOTlight on GLOW

por Derks, Sarah, van Laarhoven, Hanneke W.M.
Publicado 2023

Can we do without chemotherapy? A perspective on the combinations nivolumab-chemotherapy and nivolumab–ipilimumab in metastatic gastric and esophageal cancer

por Derks, Sarah, van Laarhoven, Hanneke W. M.
Publicado 2022

Chromosomal Instability, Selection and Competition: Factors That Shape the Level of Karyotype Intra-Tumor Heterogeneity

por van den Bosch, Tom, Derks, Sarah, Miedema, Daniël M.
Publicado 2022

Galectins in Esophageal Cancer: Current Knowledge and Future Perspectives

por Godefa, Tesfay M., Derks, Sarah, Thijssen, Victor L. J. L.
Publicado 2022

Combining Radiotherapy With Anti-angiogenic Therapy and Immunotherapy; A Therapeutic Triad for Cancer?

por Goedegebuure, Ruben S. A., de Klerk, Leonie K., Bass, Adam J., Derks, Sarah, Thijssen, Victor L. J. L.
Publicado 2019

Comparison of the tumor microenvironments of squamous cell carcinoma at different anatomical locations within the upper aerodigestive tract in relation to response to ICI therapy...

por van Duijvenvoorde, Maurice, Derks, Sarah, Bahce, Idris, Leemans, C René, van de Ven, Rieneke, Fransen, Marieke F
Publicado 2022

Methylation-Specific PCR Unraveled

por Derks, Sarah, Lentjes, Marjolein H. F. M., Hellebrekers, Debby M. E. I., de Bruïne, Adriaan P., Herman, James G., van Engeland, Manon
Publicado 2004

Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine

por Derks, Sarah, Cleven, Arjen H. G., Melotte, Veerle, Smits, Kim M., Brandes, Johann C., Azad, Nilofer, van Criekinge, Wim, de Bruïne, Adriaan P., Herman, James G., van Engeland, Manon
Publicado 2013

Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers

por Derks, Sarah, Liao, Xiaoyun, Chiaravalli, Anna M., Xu, Xinsen, Camargo, M. Constanza, Solcia, Enrico, Sessa, Fausto, Fleitas, Tania, Freeman, Gordon J., Rodig, Scott J., Rabkin, Charles S., Bass, Adam J.
Publicado 2016

Comparing treatment and outcomes in advanced esophageal, gastroesophageal junction, and gastric adenocarcinomas: a population-based study

por Pape, Marieke, Vissers, Pauline A. J., Dijksterhuis, Willemieke P. M., Bertwistle, David, McDonald, Laura, Mostert, Bianca, Derks, Sarah, Oving, Irma M., Verhoeven, Rob H. A., van Laarhoven, Hanneke W. M.
Publicado 2023

Neoadjuvant chemotherapy in older patients with gastric cancer undergoing surgery: a population-based cohort study

por Keywani, Kammy, Borgstein, Alexander B. J., Eshuis, Wietse J., Pape, Marieke, Versteeg, Kathelijn S., Derks, Sarah, van Laarhoven, Hanneke W. M., Gisbertz, Suzanne S., Verhoeven, Rob H. A., van Berge Henegouwen, Mark I.
Publicado 2023

Promoter Methylation Precedes Chromosomal Alterations in Colorectal Cancer Development

por Derks, Sarah, Postma, Cindy, Moerkerk, Peter T. M., van den Bosch, Sandra M., Carvalho, Beatriz, Hermsen, Mario A. J. A., Giaretti, Walter, Herman, James G., Weijenberg, Matty P., de Bruïne, Adriaan P., Meijer, Gerrit A., van Engeland, Manon
Publicado 2006

Circulating tumor DNA predicts outcome in metastatic gastroesophageal cancer

por van Velzen, Merel J. M., Creemers, Aafke, van den Ende, Tom, Schokker, Sandor, Krausz, Sarah, Reinten, Roy J., Dijk, Frederike, van Noesel, Carel J. M., Halfwerk, Hans, Meijer, Sybren L., Mearadji, Banafsche, Derks, Sarah, Bijlsma, Maarten F., van Laarhoven, Hanneke W. M.
Publicado 2022

The LEGACy study: a European and Latin American consortium to identify risk factors and molecular phenotypes in gastric cancer to improve prevention strategies and personalized cli...

por van Schooten, Tessa Suzanne, Derks, Sarah, Jiménez-Martí, Elena, Carneiro, Fatima, Figueiredo, Ceu, Ruiz, Erika, Alsina, Maria, Molero, Cristina, Garrido, Marcelo, Riquelme, Arnoldo, Caballero, Carmelo, Lezcano, Eva, O’Connor, Juan Manuel, Esteso, Federico, Farrés, Judith, Mas, José Manuel, Lordick, Florian, Vogt, Jeannette, Cardone, Antonella, Girvalaki, Charis, Cervantes, Andrés, Fleitas, Tania
Publicado 2022

Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiation

por Goedegebuure, Ruben S. A., Kleibeuker, Esther A., Buffa, Francesca M., Castricum, Kitty C. M., Haider, Syed, Schulkens, Iris A., ten Kroode, Luuk, van den Berg, Jaap, Jacobs, Maarten A. J. M., van Berkel, Anne-Marie, van Grieken, Nicole C. T., Derks, Sarah, Slotman, Ben J., Verheul, Henk M. W., Harris, Adrian L., Thijssen, Victor L.
Publicado 2021

Longitudinal immune monitoring of patients with resectable esophageal adenocarcinoma treated with Neoadjuvant PD-L1 checkpoint inhibition

por van den Ende, Tom, Ezdoglian, Aiarpi, Baas, Lisanne M., Bakker, Joyce, Lougheed, Sinéad M., Harrasser, Micaela, Waasdorp, Cynthia, van Berge Henegouwen, Mark I., Hulshof, Maarten C.C.M., Haj Mohammad, Nadia, van Hillegersberg, Richard, Mook, Stella, van der Laken, Conny J., van Grieken, Nicole C.T., Derks, Sarah, Bijlsma, Maarten F., van Laarhoven, Hanneke W.M., de Gruijl, Tanja D.
Publicado 2023

A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT)

por Stroes, Charlotte I, Schokker, Sandor, Khurshed, Mohammed, van der Woude, Stephanie O, Mathôt, Ron AA, Slingerland, Marije, de Vos-Geelen, Judith, Zucchetti, Massimo, Matteo, Cristina, van Dijk, Erik, Ylstra, Bauke, Thijssen, Victor, Derks, Sarah, Godefa, Tesfay, Dijksterhuis, Willemieke, Breimer, Gerben E, van Delden, Otto M, Verhoeven, Rob HA, Meijer, Sybren L, Bijlsma, Maarten F, van Laarhoven, Hanneke WM
Publicado 2022

Molecular profiles of response to neoadjuvant chemoradiotherapy in oesophageal cancers to develop personalized treatment strategies

por de Klerk, Leonie K., Goedegebuure, Ruben S. A., van Grieken, Nicole C. T., van Sandick, Johanna W., Cats, Annemieke, Stiekema, Jurrien, van der Kaaij, Rosa T., Farina Sarasqueta, Arantza, van Engeland, Manon, Jacobs, Maarten A. J. M., van Wanrooij, Roy L. J., van der Peet, Donald L., Thorner, Aaron R., Verheul, Henk M. W., Thijssen, Victor L. J. L., Bass, Adam J., Derks, Sarah
Publicado 2021

Phase II study of pembrolizumab in refractory esophageal cancer with correlates of response and survival

por de Klerk, Leonie K, Patel, Anuj K, Derks, Sarah, Pectasides, Eirini, Augustin, Jeremy, Uduman, Mohamed, Raman, Nihal, Akarca, Fahire G, McCleary, Nadine J, Cleary, James M, Rubinson, Douglas A, Clark, Jeffrey W, Fitzpatrick, Bridget, Brais, Lauren K, Cavanaugh, Megan E, Rode, Amanda J, Jean, Melissa G, Lizotte, Patrick H, Nazzaro, Matthew J, Severgnini, Mariano, Zheng, Hui, Fuchs, Charles S, Enzinger, Peter C, Bass, Adam J
Publicado 2021